UNSPSC 51442007: TFT or trifluorothymidine or trifluridine

This classification denotes a pyrimidine antagonist with the molecular formula C10H11F3N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RMW9V5RW38, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-beta-d-ribofuranosyl)-5-(trifluoromethyl)- but generally known as trifluridine, which bears US NIH Compound Identifier 6256. European Medicines Agency schedules Trifluridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11291MIG.

UNSPSC 51442007 Trifluorothymidine or trifluridine (Commodity) shows minimal recent state and local procurement activity under its nominal pharmaceutical scope. The two most recent opportunities posted under this code—one soliciting X-ray system maintenance services and one soliciting copper sulfate—bear no relationship to the code's stated product category of a fluorinated antiviral nucleoside. State and local procurement databases occasionally tag opportunities with codes that do not match the work being bought; this code appears to be one such instance.

No state and local solicitations for trifluorothymidine or trifluridine itself have appeared in recent procurement records. The code warrants a watch-only posture unless future opportunities specifically name the pharmaceutical product and clarify the actual procurement need.